Cyclerion Therapeutics's total assets for Q4 2025 were $9.98M, a decrease of -4.13% from the previous quarter. CYCN total liabilities were $900.00K for the fiscal quarter, a 2.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.